16-30353677-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_006110.3(CD2BP2):c.499C>T(p.Pro167Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000547 in 1,461,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD2BP2 | NM_006110.3 | c.499C>T | p.Pro167Ser | missense_variant | Exon 5 of 7 | ENST00000305596.8 | NP_006101.1 | |
CD2BP2 | NM_001243646.2 | c.499C>T | p.Pro167Ser | missense_variant | Exon 4 of 6 | NP_001230575.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461542Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727082
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.499C>T (p.P167S) alteration is located in exon 5 (coding exon 4) of the CD2BP2 gene. This alteration results from a C to T substitution at nucleotide position 499, causing the proline (P) at amino acid position 167 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at